APA (7th ed.) Citation

K, W., ME, S., JP, N., AM, B., S, K., MA, H., . . . AJ, N. (2024). Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL. Blood cancer journal, 14(1), 100. https://doi.org/10.1038/s41408-024-01080-0

Chicago Style (17th ed.) Citation

K, Wenzl, et al. "Multiomic Analysis Identifies a High-risk Signature That Predicts Early Clinical Failure in DLBCL." Blood Cancer Journal 14, no. 1 (2024): 100. https://doi.org/10.1038/s41408-024-01080-0.

MLA (9th ed.) Citation

K, Wenzl, et al. "Multiomic Analysis Identifies a High-risk Signature That Predicts Early Clinical Failure in DLBCL." Blood Cancer Journal, vol. 14, no. 1, 2024, p. 100, https://doi.org/10.1038/s41408-024-01080-0.